Kombucha & Rheumatoid Arthritis: Potential Benefits, Risks & Evidence Gap

What Is Kombucha?

Fermented sweetened tea (SCOBY: symbiotic culture of bacteria & yeast). Contains organic acids, polyphenols, probiotics, trace alcohol (<0.5%), B vitamins.

Theoretical Benefits for RA

• Anti-inflammatory: Polyphenols (tea-derived) inhibit NF-κB, COX-2.
• Gut-joint axis: Probiotics may modulate microbiota, reduce intestinal permeability, lower systemic inflammation.
• Antioxidant: Gluconic/glucuronic acids, DSL (D-saccharic acid-1,4-lactone) support detox pathways.

Current Evidence

• Human RCTs: NONE for RA specifically.
• Animal models: Kombucha reduced paw swelling, cytokines in adjuvant-induced arthritis (rat).
• In vitro: Inhibits inflammatory cytokines, MMPs.

Safety Concerns

• Home-brew contamination risk (pathogens, mycotoxins, excess alcohol/acid).
• Case reports: lactic acidosis, hepatotoxicity, lead poisoning (ceramic vessels).
• Immunocompromised (on biologics/steroids) → theoretical infection risk from live cultures.
• Drug interactions: may affect CYP450, anticoagulants.

Practical Guidance

1. Discuss with rheumatologist before starting.
2. If cleared: commercial pasteurized brands (GT's, Health-Ade) — 4–8 oz/day.
3. Monitor: LFTs, glucose, symptoms; discontinue if flare or adverse event.
4. Never replace DMARDs/biologics.

Kombucha may offer modest adjunctive support, but evidence is preclinical. Safety first.